On April 18th, Lotus participated the Hematology Society of Taiwan 2015 conference.
It was the first time we had a booth at the hematology society annual conference.
Not only the members of the Hematology Society, but also the representatives of other pharmaceutical companies were amazed at our booth and the bright image of new Lotus.
We have also done a little survey about the Generic Branding.
Questions were about the important factors of choosing medication, generic medication and generic company. Totally, we collected about 85 questionnaires. According to the result of the survey, physicians did care about the quality of the generic as well as if the pharmaceutical facilities have passed high-standard of inspections.
Lotus’s facility not only had TFDA PIC/s GMP, but also approved by FDA, EU and JP PMDA.
We provided international quality of generic products to the market.
Next step, we would constantly produce and import more and more high-quality oncology products to Taiwan, 25 projects in development, and aimed at being the first ranking in Taiwan and getting into Top 5 companies in Asia.
